MAP2K7 and melanoma: In contrast to ARF6 activation, deletion of Arf6 in BRAFV600E murine melanoma tumors12 reduced total BRAFV600E levels and downstream phosphorylated MEK (p-MEK) and ERK (p-ERK), detected by immunofluorescence in situ (Fig. 2a, S1f).